Exicure Inc
NASDAQ:XCUR
| Market Cap (Intraday) | 125.57M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.70 |
| 50-Day MA | $2.02 |
| 200-Day MA | $1.98 |
Exicure Inc Stock, NASDAQ:XCUR
2430 North Halsted Street, Suite 410, Chicago, Illinois 60614
United States of America
Phone: +1.847.673.1700
Number of Employees: 63
Description
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.